Fifth Åland Island conference on von Willebrand disease-Reference-Cited by-同舟云学术

Fifth Åland Island conference on von Willebrand disease

Published:2018-04-24 Issue: Volume:24 Page:5-19
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Berntorp E.¹,Ågren A.²,Aledort L.³,Blombäck M.⁴,Cnossen M. H.⁵,Croteau S. E.⁶,von Depka M.⁷,Federici A. B.⁸,Goodeve A.⁹¹⁰,Goudemand J.¹¹,Mannucci P. M.¹²,Mourik M.¹³,Önundarson P. T.¹⁴,Rodeghiero F.¹⁵,Szántó T.¹⁶,Windyga J.¹⁷

Affiliation:

1. Centre for Thrombosis and Haemostasis; Skåne University Hospital; Lund University; Malmö Sweden

2. Coagulation Unit; Department of Medicine; Division of Haematology; Karolinska University Hospital; Stockholm Sweden

3. Department of Hematology and Medical Oncology; Mount Sinai Hospital; New York NY USA

4. Department of Molecular Medicine and Surgery; Karolinska University Hospital; Stockholm Sweden

5. Erasmus University Medical Center - Sophia Children's Hospital Rotterdam; Rotterdam The Netherlands

6. Boston Children's Hospital; Boston Hemophilia Center; Harvard Medical School; Boston MA USA

7. Werlhof-Institute Hannover; Hannover Germany

8. Department of Oncology and Oncologic Hematology, Haematology and Transfusion Medicine; L. Sacco University Hospital; University of Milan; Milan Italy

9. Haemostasis Research Group; University of Sheffield; Sheffield UK

10. Sheffield Diagnostic Genetics Service; Sheffield Children's NHS Foundation Trust; Sheffield UK

11. Department of Haematology; Lille University Hospital; Lille France

12. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center; IRCCS Cà Grande Maggiore Policlinico Hospital Foundation; Milan Italy

13. Department of Molecular Cell Biology; Leiden University Medical Center; Leiden The Netherlands

14. Landspitali University Hospital; University of Iceland School of Medicine; Reykjavik Iceland

15. Department of Cell Therapy and Hematology; San Bortolo Hospital; Vicenza Italy

16. Coagulation Disorders Unit; Departments of Hematology and Clinical Chemistry (HUSLAB Laboratory Services); Helsinki University Central Hospital; Helsinki Finland

17. Department of Disorders of Hemostasis and Internal Medicine; Institute of Hematology and Transfusion Medicine; Warsaw Poland

Funder

Octapharma

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13475/fullpdf

Reference109 articles.

1. Hereditär pseudohemofili;Von Willebrand;Fin Lakaresallsk Handl,1926

2. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor;Sadler;J Thromb Haemost,2006

3. Making a diagnosis of VWD;Branchford;Hematology Am Soc Hematol Educ Program,2012

4. Clinical and laboratory diagnosis of VWD;Federici;Hematology Am Soc Hematol Educ Program,2014

5. Absence of tubular structures and immunolabeling for von Willebrand factor in the platelet α-granules from porcine von Willebrand disease;Cramer;Blood,1986

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phage display broadly identifies inhibitor‐reactive regions in von Willebrand factor;Journal of Thrombosis and Haemostasis;2021-07-28

2. Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms;Seminars in Thrombosis and Hemostasis;2021-06-15

3. Phage Display Broadly Identifies Inhibitor-reactive Regions in von Willebrand Factor;2021-03-09

4. Protocolo diagnóstico de las alteraciones de la hemostasia;Medicine - Programa de Formación Médica Continuada Acreditado;2020-11

5. Updated overview on von Willebrand disease: focus on the interest of genotyping;Expert Review of Hematology;2019-10-06